Alternatives to EyeGate Pharmaceuticals

AI-powered eye exam for early detection of neurodegenerative diseases like Alzheimer's.

Pioneering vision restoration therapies for severe retinal degenerations.

A global oncology company developing and commercializing innovative cancer treatments.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered platform accelerating biological research and drug discovery.

Alcon is a global leader in eye care, providing a broad portfolio of products to enhance sight and improve lives.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

Developing novel male contraceptives.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing nitric oxide-releasing foam technology for chronic wound healing.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Mapping cell-cell communication at scale in human tissue.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

A global pharmaceutical company focused on developing and marketing innovative treatments.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company focused on developing treatments for rare metabolic diseases.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery and development platform for biologics.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech company developing next-generation gene writing tools for advanced therapies.

Advance every cancer decision.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.